BR0010712A - Anticorpo isozima adenilato cinase mitocondrial anti - humana, formulação diagnóstica e kit diagnóstico para doença cardìaca - Google Patents

Anticorpo isozima adenilato cinase mitocondrial anti - humana, formulação diagnóstica e kit diagnóstico para doença cardìaca

Info

Publication number
BR0010712A
BR0010712A BR0010712-3A BR0010712A BR0010712A BR 0010712 A BR0010712 A BR 0010712A BR 0010712 A BR0010712 A BR 0010712A BR 0010712 A BR0010712 A BR 0010712A
Authority
BR
Brazil
Prior art keywords
diagnostic
adenylate kinase
heart disease
formulation
human mitochondrial
Prior art date
Application number
BR0010712-3A
Other languages
English (en)
Inventor
Hyo Joon Kim
Key Seung Cho
Sang Min Lee
Original Assignee
Hyo Joon Kim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyo Joon Kim filed Critical Hyo Joon Kim
Publication of BR0010712A publication Critical patent/BR0010712A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1229Phosphotransferases with a phosphate group as acceptor (2.7.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Patente de Invenção: "ANTICORPO ISOZIMA ADENILATO CINASE MITOCONDRIAL ANTI - HUMANA, FORMULAçãO DIAGNóSTICA E KIT DIAGNóSTICO PARA DOENçA CARDìACA". A presente invenção refere-se a uma formulação imunológica e um kit diagnóstico para doença cardíaca usando isozimas adenilato cinase mitoncondrial humana. A presente invenção provê uma formulação imunológica e um kit diagnóstico para doença cardíaca, que são caracterizados pelo uso de isozimas adenilato cinase mitocondrial que existem em uma célula miocardíaca entre células de músculo, mas não em uma célula muscular de esqueleto, como um marcador diagnóstico para doenças cardíacas e que permitem diagnóstico mais correto e fácil de doença cardíaca.
BR0010712-3A 2000-02-08 2000-08-10 Anticorpo isozima adenilato cinase mitocondrial anti - humana, formulação diagnóstica e kit diagnóstico para doença cardìaca BR0010712A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0005808A KR100414637B1 (ko) 2000-02-08 2000-02-08 사람 미토콘드리아 아데닐레이트 키나제 이소자임들에대한 항체와 면역학적 제제 및 심장질환 진단키트
PCT/KR2000/000882 WO2001058482A1 (en) 2000-02-08 2000-08-10 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease

Publications (1)

Publication Number Publication Date
BR0010712A true BR0010712A (pt) 2002-02-05

Family

ID=19644714

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010712-3A BR0010712A (pt) 2000-02-08 2000-08-10 Anticorpo isozima adenilato cinase mitocondrial anti - humana, formulação diagnóstica e kit diagnóstico para doença cardìaca

Country Status (14)

Country Link
US (1) US7514227B2 (pt)
EP (1) EP1165133B1 (pt)
JP (1) JP3736798B2 (pt)
KR (1) KR100414637B1 (pt)
CN (1) CN1368888B (pt)
AT (1) ATE493658T1 (pt)
AU (1) AU784153B2 (pt)
BR (1) BR0010712A (pt)
CA (1) CA2366468C (pt)
DE (1) DE60045444D1 (pt)
ES (1) ES2355128T3 (pt)
HK (1) HK1049121B (pt)
RU (1) RU2262939C2 (pt)
WO (1) WO2001058482A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004029094A1 (en) * 2002-09-28 2004-04-08 Sj Biomed Inc Monoclonal antibody specific for human mitochondrial adenylate kinase isozyme 3
NZ570008A (en) * 2006-02-09 2011-10-28 Univ South Florida Detection of ovarian cancer by elevated levels of Bcl-2 in urine
GB0913258D0 (en) * 2009-07-29 2009-09-02 Dynex Technologies Inc Reagent dispenser
US9523701B2 (en) 2009-07-29 2016-12-20 Dynex Technologies, Inc. Sample plate systems and methods
CN104237505B (zh) * 2014-09-17 2016-05-04 杭州特马赛生物技术有限公司 一种检测阿司匹林和氯吡咯雷药物双重抵抗的试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417593D0 (en) * 1994-09-01 1994-10-19 Secr Defence Luciferase labelling method
US5856160A (en) * 1997-03-31 1999-01-05 Incyte Pharmaceuticals, Inc. Mitochondrial adenylate kinase
US6558903B1 (en) * 1999-06-30 2003-05-06 Millennium Pharmaceuticals, Inc. Kinases and uses thereof
AU2001237178A1 (en) * 2000-02-25 2001-09-03 Metriogene Biosciences Inc. Endometriosis-related markers and uses thereof

Also Published As

Publication number Publication date
CN1368888B (zh) 2010-11-03
KR20010077769A (ko) 2001-08-20
EP1165133B1 (en) 2010-12-29
RU2262939C2 (ru) 2005-10-27
US20070122846A1 (en) 2007-05-31
CA2366468A1 (en) 2001-08-16
HK1049121A1 (en) 2003-05-02
ES2355128T3 (es) 2011-03-23
JP3736798B2 (ja) 2006-01-18
DE60045444D1 (de) 2011-02-10
JP2003522158A (ja) 2003-07-22
AU6734800A (en) 2001-08-20
AU784153B2 (en) 2006-02-09
KR100414637B1 (ko) 2004-01-13
US7514227B2 (en) 2009-04-07
EP1165133A4 (en) 2005-06-29
ATE493658T1 (de) 2011-01-15
CA2366468C (en) 2010-02-02
EP1165133A1 (en) 2002-01-02
WO2001058482A1 (en) 2001-08-16
HK1049121B (zh) 2011-01-14
CN1368888A (zh) 2002-09-11

Similar Documents

Publication Publication Date Title
Ruff Morphological adaptation to climate in modern and fossil hominids
ATE313273T1 (de) Ernährungszusammensetzung
Zillmann et al. Comparison of training and anthropometric characteristics between recreational male half-marathoners and marathoners
ATE369425T1 (de) Antikörper gegen eine lar-phosphatase untereinheit
NI200800193A (es) Anticuerpos humanos anti-il-23, composiciones, métodos y usos.
UA95238C2 (uk) Імуногенна композиція
BRPI0407827A (pt) compostos de aminoeteroarila como inibidores de proteìna cinase
CY1112891T1 (el) Πολλαπλοεπιλεκτικοι αποανοσοποιημενοι cd3-συνδετες
BR0011854A (pt) Agonistas de receptores de a2a de c-pirazola
BRPI0011856B8 (pt) agonistas de receptor a2a de n-pirazol
TR200101673A2 (tr) Düz kas hücrelerinin sıkışmasıyla ilgili hastalıkların tedavisindeki kompozisyonlar için biyokimyasal maddeler.
Barber Secular changes in standards of bodily attractiveness in American women: Different masculine and feminine ideals
Kireilis et al. The relationships of external fat to physical education activities and fitness tests
WO2004110369A3 (en) Cell surface protein associated with human chronic lymphocytic leukemia
EP1165133A4 (en) HUMAN MITOCHONDRIAL ADENYLATE KINASE ANTI-ISOZYME ANTIBODY, DIAGNOSTIC PREPARATION AND DIAGNOSTIC KIT FOR CARDIAC DISEASE
Singh Physical growth of Gaddi Rajputs of Dhaula Dhar range of the Himalayas
BR0312483A (pt) Anticorpos e seus usos
Ceria-Ulep et al. Assessing physical activity and function in the Filipino older adults.
NZ595758A (en) Thorium-227 for use in radiotherapy of soft tissue disease
Misra et al. A new fossil fish, Jhingrania roonwali, from the Rajmahal Hills, India
Miller Exercise Training Beneficial for Older Women with CAD
WO2006042005A3 (en) Global gene expression profiling of circulating tumor cells
Peterson Promotion of heart health in mid-life women: the church-based heart and soul physical activity program
KANO SERUM LIPIDS AND LIPOPROTEINS-A Curse or a Blessing?
INACTIVITY BIRTHWEIGHT, LIFETIME OBESITY, AND PHYSICAL FUNCTIONING IN MID-ADULTHOOD: A NATIONWIDE BIRTH COHORT STUDY

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2162 DE 12/06/2012.